A FRAX® model for the assessment of fracture probability in Belgium

Osteoporosis International

Volumn 22, Issue 2, 2011, Pages 453-461

  Johansson, H ^a   Kanis, J A ^a   McCloskey, E V ^a   Oden A ^a   Devogelaer, J P ^b   Kaufman, J M ^c   Neuprez, A ^d   Hiligsmann, M ^d   Bruyere, O ^d   Reginster, J Y ^d  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

^d UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

10 year fracture probability; Clinical risk factors; FRAX ; Hip fracture; Osteoporotic fracture

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; GLUCOCORTICOID; RALOXIFENE; STRONTIUM RANELATE;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ALGORITHM; ARTICLE; BELGIUM; BODY MASS; BONE DENSITY; COMPUTER MODEL; FAMILY HISTORY; FEMALE; FEMUR NECK; FOREARM FRACTURE; FRAGILITY FRACTURE; HEALTH CARE POLICY; HIGH RISK PATIENT; HIP FRACTURE; HUMAN; HUMERUS FRACTURE; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROBABILITY; REIMBURSEMENT; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SEX DIFFERENCE; SMOKING; SPINE FRACTURE; VERTEBRA FRACTURE; WORLD HEALTH ORGANIZATION;

AGED; AGED, 80 AND OVER; ALGORITHMS; BELGIUM; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; OSTEOPOROTIC FRACTURES; RISK ASSESSMENT; RISK FACTORS;

EID: 78651513069     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-010-1218-1     Document Type: Article

References (59)

1. JA Kanis LJ Melton 3rd C Christiansen, et al. 1994 The diagnosis of osteoporosis J Bone Miner Res 9 1137 1141 1:STN:280:DyaK2M%2FmslSisA%3D%3D 7976495 10.1002/jbmr.5650090802
2. AC Looker HW Wahner WL Dunn, et al. 1998 Updated data on proximal femur bone mineral levels of US adults Osteoporos Int 8 468 489 1:STN:280: DyaK1M%2FmslensA%3D%3D 9850356 10.1007/s001980050093
3. JA Kanis EV McCloskey H Johansson A Oden LJ Melton N Khaltaev 2008 A reference standard for the description of osteoporosis Bone 42 467 475 1:CAS:528:DC%2BD1cXitVOmtbk%3D 18180210 10.1016/j.bone.2007.11.001
4. JA Kanis P Delmas P Burckhardt C Cooper D Torgerson On behalf of the European Foundation for Osteoporosis and Bone Disease 1977 Guidelines for diagnosis and management of osteoporosis Osteoporos Int 7 390 406 10.1007/BF01623782
5. Kanis on behalf of the World Health Organization Scientific Group. JA (2008) Assessment of osteoporosis at the primary health-care level. Technical Report. WHO Collaborating Centre, University of Sheffield, UK.
6. European Community. Report on osteoporosis in the European Community. 1998. EC, Strasbourg
7. Royal College of Physicians (1999) Osteoporosis: clinical guidelines for the prevention and treatment. Royal College of Physicians, London
8. JA Kanis O Johnell A Oden, et al. 2000 Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis Bone 27 585 590 1:STN:280:DC%2BD3M%2FktlOqsg%3D%3D 11062343 10.1016/S8756-3282(00)00381- 1
9. SC Schuit M van der Klift AE Weel, et al. 2004 Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study Bone 34 195 202 1:STN:280:DC%2BD2c%2FltVCjsg%3D%3D 14751578 10.1016/j.bone.2003.10.001
10. JA Kanis O Johnell A Oden, et al. 2000 Risk of hip fracture derived from relative risks: an analysis applied to the population of Sweden Osteoporos Int 11 120 127 1:STN:280:DC%2BD3c3lsVeguw%3D%3D 10793869 10.1007/PL00004173
11. JA Kanis A Oden O Johnell, et al. 2007 The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women Osteoporos Int 18 1033 1046 1:STN:280: DC%2BD2sznvV2hug%3D%3D 17323110 10.1007/s00198-007-0343-y
12. JA Kanis O Johnell A Oden, et al. 2008 FRAX and the assessment of fracture probability in men and women from the UK Osteoporos Int 19 385 397 1:STN:280:DC%2BD1c7nvF2ntA%3D%3D 18292978 10.1007/s00198-007-0543-5
13. JA Kanis O Johnell C De Laet B Jonsson A Oden A Oglesby 2002 International variations in hip fracture probabilities: implications for risk assessment J Bone Miner Res 17 1237 1244 12096837 10.1359/jbmr.2002.17.7.1237
14. B Dawson-Hughes AN Tosteson LJ Melton 3rd, et al. 2008 Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA Osteoporos Int 19 449 458 1:STN:280:DC%2BD1c7nvF2nsQ%3D%3D 18292975 10.1007/s00198-008-0559-5
15. S Fujiwara T Nakamura H Orimo, et al. 2008 Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX) Osteoporos Int 19 429 435 1:STN:280:DC%2BD1c7nvF2ntw%3D%3D 18292977 10.1007/s00198-007-0544-4
16. Lippuner K, Johansson H, Rizzoli R, Kanis JA (2009) Remaining lifetime and absolute 10-year probabilities of osteoporotic fracture in Swiss men and women. Osteoporosis Int 20:1131-1140
17. M Hiligsmann O Bruyère O Ethgen HJ Gathon JY Reginster 2008 Lifetime absolute risk of hip and other osteoporotic fracture in Belgian women Bone 43 991 994 18817901 10.1016/j.bone.2008.08.119
18. United Nations population division (2003). World population prospects: the 2002 revision and world urban prospects. Population Division of the Dept Economic and Social Affairs of the UN Secretariat.
19. JA Kanis A Oden O Johnell B Jonsson C de Laet A Dawson 2001 The burden of osteoporotic fractures: a method for setting intervention thresholds Osteoporos Int 12 417 427 1:STN:280:DC%2BD3MzovF2gtw%3D%3D 11444092 10.1007/s001980170112
20. S Boonen JM Kaufman JY Reginster JP Devogelaer on behalf of the Belgian Bone Club (BBC) 2003 Patient assessment using standardized bone mineral density values and a national reference database: implementing uniform thresholds for the reimbursement of osteoporosis treatments in Belgium Osteoporos Int 14 110 115 1:STN:280:DC%2BD3s3htlKgsg%3D%3D 12730782
21. S Goemaere D Vanderschueren JM Kaufman On behalf of the Belgian Bone Club (BBC) the Network on Male Osteoporosis in Europe (NEMO), et al. 2007 Dual energy x-ray absorptiometry-based assessment of male patients using standardized bone density values and a national reference database J Clin Densitom 10 25 33 17289523 10.1016/j.jocd.2006.10.002
22. C De Laet JA Kanis A Oden, et al. 2005 Body mass index as a predictor of fracture risk: a meta-analysis Osteoporos Int 16 1330 1338 15928804 10.1007/s00198-005-1863-y
23. JA Kanis A Oden H Johansson F Borgström O Ström E McCloskey 2009 FRAX® and its applications to clinical practice Bone 44 734 743 19195497 10.1016/j.bone.2009.01.373
24. H Johansson JA Kanis A Oden O Johnell E McCloskey 2009 BMD, clinical risk factors and their combination for hip fracture prevention Osteoporos Int 20 1675 1682 1:STN:280:DC%2BD1MngtFaquw%3D%3D 19291344 10.1007/s00198-009-0845-x
25. DM Black M Steinbuch L Palermo, et al. 2001 An assessment tool for predicting fracture risk in postmenopausal women Osteoporos Int 12 519 528 1:STN:280:DC%2BD3MvosFagtQ%3D%3D 11527048 10.1007/s001980170072
26. H Burger CE de Laet AE Weel A Hofman HA Pols 1999 Added value of bone mineral density in hip fracture risk scores Bone 25 369 374 1:STN:280: DyaK1MvitlegsQ%3D%3D 10495142 10.1016/S8756-3282(99)00173-8
27. G Albrand F Munoz E Sornay-Rendu F DuBoeuf PD Delmas 2001 Independent predictors of all osteoporosis-related fractures in healthy postmenopausal women: the OFELY Study Bone 32 78 85 10.1016/S8756-3282(02)00919-5
28. J Carroll MA Testa K Erat MS LeBoff G El-Hajj Fuleihan 1997 Modelling fracture risk using bone density, age, and years since menopause Amer J Prevent Med 13 447 452 1:STN:280:DyaK1c%2FnslKgsA%3D%3D
29. P Dargent-Molina MN Douchin C Cormier PJ Meunier G Bréart EPIDOS Study Group 2002 Use of clinical risk factors in elderly women with low bone mineral density to identify women at higher risk of hip fracture: the EPIDOS prospective study Osteoporos Int 13 593 599 1:STN:280:DC%2BD38zmslSmtg%3D%3D 12111021 10.1007/s001980200078
30. CJ Girman JM Chandler SI Zimmerman, et al. 2002 Prediction of fracture in nursing home residents J Amer Geriatr Soc 50 1341 1347 10.1046/j.1532-5415. 2002.50354.x
31. RJ Honkanen K Honkanen H Kröger E Alhava M Tuppurainen S Saarikoski 2000 Risk factors for perimenopausal distal forearm fracture Osteoporos Int 11 265 270 1:STN:280:DC%2BD3c3osVamug%3D%3D 10824244 10.1007/s001980050291
32. WD Leslie C Metge EA Salamon CK Yuen 2002 Bone mineral density testing in healthy postmenopausal women: the role of clinical risk factor assessment in determining fracture risk J Clin Densitom 5 117 130 12110755 10.1385/JCD:5:2:117 Erratum in: J Clin Densitom 2002;5:319
33. PD Miller S Barlas S Brenneman, et al. 2004 An approach to identifying osteopenic women at increased short-term risk of fracture Arch Int Med 164 1113 1120 10.1001/archinte.164.10.1113
34. G Westfall R Littlefield A Heaton S Martin 2001 Methodology for identifying patients at high risk for osteoporotic fracture Clin Ther 23 1570 1588 1:STN:280:DC%2BD3Mrkt1Crsg%3D%3D 11589269 10.1016/S0149-2918(01)80129-6
35. CS Colón-Emeric CF Pieper MB Artz 2002 Can historical and functional risk factors be used to predict fractures in community-dwelling older adults? Development and validation of a clinical tool Osteoporos Int 13 955 961 12459938 10.1007/s001980200133
36. T-P van Staa H-GM Leufkens C Cooper 2002 Utility of medical and drug history in fracture risk prediction among men and women Bone 31 508 514 12398948 10.1016/S8756-3282(02)00848-7
37. TP van Staa P Geusens HA Pols C de Laet HG Leufkens C Cooper 2005 A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids Quart J Med 98 191 198
38. CW McGrother MM Donaldson D Clayton KR Abrams M Clarke 2002 Evaluation of a hip fracture risk score for assessing elderly women: the Melton Osteoporotic Fracture (MOF) study Osteoporos Int 13 89 96 1:STN:280:DC%2BD387ltFSqtA%3D%3D 11883411 10.1007/s198-002-8343-6
39. LC Walter LY Lui C Eng KE Covinsky 2003 Risk of hip fracture in disabled community-living older adults J Amer Geriatr Soc 51 50 55 10.1034/j.1601-5215. 2002.51009.x
40. ND Nguyen SA Frost JR Center JA Eisman TV Nguyen 2008 Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks Osteoporos Int 19 1431 1444 1:STN:280:DC%2BD1crnvVehtw%3D%3D 18324342 10.1007/s00198-008-0588-0
41. JA Kanis O Johnell A Oden H Johansson EV McCloskey 2008 FRAX™ and the assessment of fracture probability in men and women from the UK Osteoporos Int 19 385 397 1:STN:280:DC%2BD1c7nvF2ntA%3D%3D 18292978 10.1007/s00198-007- 0543-5
42. JA Kanis A Oden H Johansson F Borgström O Ström 2009 McCloskey E (2009)FRAX® and its applications to clinical practice Bone 44 734 743 19195497 10.1016/j.bone.2009.01.373
43. Committee for Medicinal Products for Human Use (CHMP) (2006) Guideline on the evaluation of Medicinal products in the treatment of primary osteoporosis. Ref CPMP/EWP/552/95Rev.2. London, CHMP. Nov 2006.
44. KG Saag R Emkey TJ Schnitzer JP Brown F Hawkins S Goemaere, et al. 1998 Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-induced Osteoporosis Intervention Study Group New Engl J Med 339 292 299 1:CAS:528:DyaK1cXlsVOitr4%3D 9682041 10.1056/ NEJM199807303390502
45. JD Adachi KG Saag PD Delmas UA Liberman RD Emkey E Seeman, et al. 2001 Two year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomised, double-blind, placebo-controlled extension trial Arthritis Rheum 44 202 211 1:CAS:528:DC%2BD3MXht1yiu7o%3D 11212161 10.1002/1529-0131(200101)44:1<202:: AID-ANR27>3.0.CO;2-W
46. JY Reginster HW Minne OH Sorensen, et al. 2000 Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral efficacy with risedronate therapy (VERT) study group Osteoporos Int 11 83 91 1:CAS:528:DC%2BD3cXhvFGgsr0%3D 10663363 10.1007/s001980050010
47. JE Roussow GL Anderson RL Prentice AZ LaCroix C Kooperberg ML Stefanick, et al. 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial JAMA 288 321 333 10.1001/jama.288.3.321
48. EV McCloskey M Beneton D Charlesworth K Kayan D deTakats A Dey, et al. 2007 Clodronate reduces the incidence of fractures in community dwelling elderly women unselected for osteoporosis: results of a double-blind, placebo-controlled randomized study J Bone Miner Res 22 135 141 1:CAS:528:DC%2BD2sXhtVWnurs%3D 17042717 10.1359/jbmr.061008
49. MC Chapuy ME Arlot PD Delmas PJ Meunier 1994 Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women BMJ 308 1081 1082 1:STN:280:DyaK2c3islKnuw%3D%3D 8173430
50. JA Kanis I Barton O Johnell 2005 Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture Osteoporos Int 16 475 482 1:CAS:528:DC%2BD2MXlsFSku7Y%3D 15875093 10.1007/s00198-004-1698-y
51. EV McCloskey P Selby M Davies, et al. 2004 Clodronate reduces vertebral fracture risk in women with post-menopausal or secondary osteoporosis: results of a double blind placebo-controlled 3 year study J Bone Miner Res 19 728 736 1:CAS:528:DC%2BD2cXktFGksrs%3D 15068495 10.1359/jbmr.040116
52. C Roux J-Y Reginster J Fechtenbaum S Kolta A Sawicki Z Tulassay, et al. 2006 Vertebral fracture with reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors J Bone Miner Res 21 536 542 1:CAS:528:DC%2BD28Xkt1Kqsrc%3D 16598373 10.1359/jbmr.060101
53. R Marcus O Wang J Satterwhite, et al. 2003 The skeletal response to teriparatide is largely independent of age, initial bone mineral density and prevalent vertebral fractures in postmenopausal women with osteoporosis J Bone Miner Res 18 18 23 1:CAS:528:DC%2BD3sXltFKmtQ%3D%3D 12510801 10.1359/jbmr.2003.18.1.18
54. O Johnell JA Kanis DM Black, et al. 2004 Association between baseline risk factors and vertebral fracture risk in the Multiple Outcomes of Raloxifene Evaluation (MORE) study J Bone Miner Res 19 764 772 1:CAS:528: DC%2BD2cXktFGks74%3D 15068500 10.1359/jbmr.040211
55. H Johansson A Oden O Johnell B Jonsson C De Laet A Oglesby, et al. 2004 Optimisation of BMD measurements to identify high risk groups for treatment-a test analysis J Bone Miner Res 19 906 913 15190881 10.1359/jbmr.2004.19.6.906
56. EV McCloskey H Johansson A Oden S Vasireddy K Kayan K Pande T Jalava JA Kanis 2009 Ten-year fracture probability identifies women who will benefit from clodronate therapy-additional results from a double blind, placebo controlled randomised study Osteoporos Int 20 811 818 1:CAS:528:DC%2BD1MXjvFaqt78%3D 19002369 10.1007/s00198-008-0786-9
57. JA Kanis H Johansson A Oden EV McCloskey 2009 Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX® Bone 44 49 54
58. Johansson H, Kanis JA, Borgström F, Ström O, Svensson O, Mellström D (2009) FRAX® ett stöd för frakturprevention. Lakar Tidningen
59. JA Kanis EV McCloskey H Johansson O Strom F Borgstrom A Oden and the National Osteoporosis Guideline Group 2008 Case finding for the management of osteoporosis with FRAX®-assessment and intervention thresholds for the UK Osteoporos Int 19 1395 1408 1:STN:280:DC%2BD1crnvFelug%3D%3D 18751937 10.1007/s00198-008-0712-1 Erratum published 2009 Osteoporos Int 20, 499-502